Clinical Trial Update: Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa [NA]

View source ↗

Summary

A clinical trial evaluating cholecystokinin for reducing binge eating in bulimia nervosa was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bulimia Nervosa

Drugs mentioned

• Cholecystokinin (Cholecystokinin)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Bulimia Nervosa, Eating Disorders | NA | Status: TERMINATED